Literature DB >> 21659341

Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic.

Andrew S Artz1, Michael J Thirman.   

Abstract

BACKGROUND: To accurately determine the causes of anemia and proportion of unexplained anemia in a racially diverse cohort of older adults after a comprehensive and standardized evaluation.
METHODS: We evaluated results from a single-institutional university anemia clinic. Patients with anemia, defined as a hemoglobin less than 13.0 g/dL for men and less than 12.0 g/dL for women, underwent a prospective standardized history, physical examination, and laboratory measures, with additional studies including bone marrow examination as indicated. Empiric treatment trials were given for identified deficiencies.
RESULTS: One hundred and seventy-four primarily community-dwelling adults aged 65 years and older were evaluable. African Americans accounted for 69% of patients and whites were 27%. Anemia etiologies included iron deficiency anemia at 25.3%, anemia of chronic inflammation at 9.8%, and hematologic malignancy in 7.5%. Unexplained anemia in the elderly accounted for 43.7% and predominated in both African Americans and whites. The prevalence of iron deficiency anemia and hematologic malignancies did not differ by race. Unexplained anemia in the elderly showed a consistent phenotype composed of a hypoproliferative mild-to-moderate anemia with suppressed serum erythropoietin. Specifically, erythropoietin levels showed no correlation with hemoglobin concentration in unexplained anemia in the elderly (r = -.15, p = .19) as opposed to iron deficiency anemia (r = -.63, p < .0001).
CONCLUSIONS: In summary, an intensive hematologic evaluation reveals a wide number of anemia etiologies among older adults, including 7.5% with hematologic malignancies; nevertheless, unexplained anemia in the elderly prevails as the most common category in whites and African Americans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659341     DOI: 10.1093/gerona/glr090

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  33 in total

1.  The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

Authors:  Peter J Snyder; Susan S Ellenberg; Glenn R Cunningham; Alvin M Matsumoto; Shalender Bhasin; Elizabeth Barrett-Connor; Thomas M Gill; John T Farrar; David Cella; Raymond C Rosen; Susan M Resnick; Ronald S Swerdloff; Jane A Cauley; Denise Cifelli; Laura Fluharty; Marco Pahor; Kristine E Ensrud; Cora E Lewis; Mark E Molitch; Jill P Crandall; Christina Wang; Matthew J Budoff; Nanette K Wenger; Emile R Mohler; Diane E Bild; Nakela L Cook; Tony M Keaveny; David L Kopperdahl; David Lee; Ann V Schwartz; Thomas W Storer; William B Ershler; Cindy N Roy; Leslie J Raffel; Sergei Romashkan; Evan Hadley
Journal:  Clin Trials       Date:  2014-06       Impact factor: 2.486

2.  Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age.

Authors:  Bryan J McCranor; Jacqueline M Langdon; Olivier D Prince; Laurette K Femnou; Alan E Berger; Chris Cheadle; Curt I Civin; Airie Kim; Seth Rivera; Tomas Ganz; Sophie Vaulont; Qian-Li Xue; Jeremy D Walston; Cindy N Roy
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

Review 3.  Evaluation and management of anemia in the elderly.

Authors:  Lawrence Tim Goodnough; Stanley L Schrier
Journal:  Am J Hematol       Date:  2014-01       Impact factor: 10.047

4.  The Relationship between Nutritional Status, Anemia and Other Vitamin Deficiencies in the Elderly Receiving Home Care.

Authors:  C Emiroglu; S Görpelioglu; C Aypak
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

5.  A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.

Authors:  Elizabeth Price; Andrew S Artz; Huiman Barnhart; Shelly Sapp; Gordon Chelune; William B Ershler; Jeremy D Walston; Victor R Gordeuk; Nathan A Berger; David Reuben; Josef Prchal; Sunil V Rao; Cindy N Roy; Mark A Supiano; Stanley L Schrier; Harvey Jay Cohen
Journal:  Blood Cells Mol Dis       Date:  2014-07-25       Impact factor: 3.039

6.  [Anemia in the elderly].

Authors:  G Röhrig; R J Schulz
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

7.  Malnutrition in Very Old Hospitalized Patients: A New Etiologic Factor of Anemia?

Authors:  E Frangos; A Trombetti; C E Graf; V Lachat; N Samaras; U M Vischer; D Zekry; R Rizzoli; F R Herrmann
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

8.  Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.

Authors:  Bryan J McCranor; Min Jung Kim; Nicole M Cruz; Qian-Li Xue; Alan E Berger; Jeremy D Walston; Curt I Civin; Cindy N Roy
Journal:  Blood Cells Mol Dis       Date:  2013-10-09       Impact factor: 3.039

9.  Anemia in the elderly: clinical implications and new therapeutic concepts.

Authors:  Reinhard Stauder; Swee Lay Thein
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

10.  Unexplained anaemia in the elderly is characterised by features of low grade inflammation.

Authors:  Andrew S Artz; Qian-Li Xue; Amittha Wickrema; Charles Hesdorffer; Luigi Ferrucci; Jacqueline M Langdon; Jeremy D Walston; Cindy N Roy
Journal:  Br J Haematol       Date:  2014-06-17       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.